Drug Discovery Research aimed at treating central nervous system (CNS) diseases has led to the discovery of several medicines that are now being used in practice. On the other hand, not all medications can relieve patients from problems associated with their diseases, and CNS disorder is still an area with many unmet medical needs.
Sphere "Digital × Neuroscience" aims to provide medical solutions that utilize digital technology to help patients and caregivers supporting the patients addressing daily problems caused by CNS disorders. In addition, by combining multiple medical solutions, we aim to provide personalized solutions tailored to individual symptoms. In the long term, we aim to prevent the onset of disease and prevent the worsening of symptoms by early detection and to improve detection of various symptoms recognized within CNS disorders through the acquisition of various biometric information.
Assets and capabilities that Astellas expects from its partners
1) Sensing device system that proposes to objectively predict disease onset and changes in problematic symptoms (for example, sleep disorders and impulsive psychiatric symptoms) from biometric data by following their time courses.
2) Neuromodulation device that proposes to alleviate disease symptoms by nerve stimulation using various modality (electricity, light, sound, vibration, etc.)